KMT2A plays a multifaceted role in cancer, promoting tumor invasion and metastasis in colorectal cancer [120], driving oncogenesis in aggressive lymphoid and myeloid leukemias, and influencing cell viability, migration, and apoptosis in cervical cancer through modulation of apoptosis-related proteins [120,121]. The gene discussed is KMT2A; the disease is neoplasm.